medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2023, Number 3

<< Back Next >>

Cir Plast 2023; 33 (3)

Breast implants in times of lymphoma and COVID-19. Have the complications increased?

Vélez-Benítez E, Cuenca-Pardo J, Torres-Gómez B, Ramírez-Montañana A, Vallarta-Rodríguez RA, Iribarren-Moreno R, Ramos-Gallardo G, Lira-Álvarez MC

Language: Spanish
References: 47
Page: 100-107
PDF size: 233.20 Kb.


ABSTRACT

Breast implant-associated lymphoma (BIA-ALCL) has been linked to macro-textured shells, which has caused most surgeons to no longer place textured implants. COVID-19 and the vaccines cause the activation of the immune system, including immunologically active cells such as macrophages, T lymphocytes and myofibroblasts that are found around breast implants, with inflammatory reactions, which have been associated with an increase in surgical complications of breast implants. We carried out a survey among the members of the Mexican Association of Plastic, Aesthetic and Reconstructive Surgery, to identify the impact that the COVID-19 pandemic and lymphoma (BIA-ALCL) has had on breast augmentation surgery with implants. 456 associates participated, which represent a very significant sample. Most are applying smooth or nano or microtextured implants; there is a marked tendency to stop using textured implants. The pandemic had a minimal effect on the frequency of breast augmentation surgery with implants and complications. Most of the respondents recognize the impact of lymphoma and its manifestations; however, there are still many surgeons who ignore the clinical findings and what studies should be carried out for the diagnosis of the disease and do not have a letter of informed consent specific for risks of breast implants.


REFERENCES

  1. ¿Por qué las mujeres se someten al aumento de senos? Rev SEMANA: Disponible en: https://www.semana.com/vida-moderna/articulo/por-que-mujeres-someten-aumento-senos/267423-3/

  2. Caldevilla DD. La imagen de la cirugía estética y su presencia en los medios de comunicación. Sociedad Española de Estudios de la Comunicación Iberoamericana Madrid, España. 2007, pp. 83-172

  3. ISAPS GLOBAL SURVEY 2021. Available in: https://www.isaps.org/discover/about-isaps/global-statistics/

  4. Comunicado de la FDA Agosto 2022. Informe de dispositivos médicos sobre el linfoma anaplásico de células grandes asociado a implantes mamarios. Disponible en: https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-breast-implant-associated-anaplastic-large-cell-lymphoma

  5. Hwang MJ, Brown H, Murrin R, Momtahan N, Sterne GD. Breast implant-associated anaplastic large cell lymphoma: a case report and literature review. Aesthetic Plast Surg 2015; 39 (3): 391-5. doi: 10.1007/s00266-015-0463-2.

  6. Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019; 143 (3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 30S-40S. doi: 10.1097/PRS.0000000000005567.

  7. Lajevardi SS, Rastogi P, Isacson D, Deva AK. What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)? JPRAS Open 2022; 32: 34-42. doi: 10.1016/j.jpra.2021.11.006.

  8. Deva AK, Turner SD, Kadin ME, Magnusson MR, Prince HM, Miranda RN et al. Etiology of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): current directions in research. Cancers (Basel) 2020; 12 (12): 3861. doi: 10.3390/cancers12123861.

  9. Lee JH. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). Yeungnam Univ J Med 2021; 38 (3): 175-182. doi: 10.12701/yujm.2020.00801.

  10. Akhavan AA, Wirtz EC, Ollila DW, Bhatt N. An unusual case of BIA-ALCL Associated with prolonged/complicated biocell-textured expander, followed by smooth round breast implant exposure, and concurrent use of adalimumab. Plast Reconstr Surg 2021; 148 (2): 299-303. doi: 10.1097/PRS.0000000000008155.

  11. K Groth A, Graf R. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and the textured breast implant crisis. Aesthetic Plast Surg. 2020; 44 (1): 1-12. doi: 10.1007/s00266-019-01521-3. Epub 2019. Erratum in: Aesthetic Plast Surg. 2020; 44 (5): 1951.

  12. Santanelli Di Pompeo F, Panagiotakos D, Firmani G, Sorotos M. BIA-ALCL Epidemiological findings from a retrospective study of 248 cases extracted from relevant case reports and series: a systematic review. Aesthet Surg J 2023; 43 (5): 545-555. doi: 10.1093/asj/sjac312. Erratum in: Aesthet Surg J. 2023 Feb 22;: PMID: 36441968.

  13. Sharma K, Gilmour A, Jones G, O'Donoghue JM, Clemens MW. A systematic review of outcomes following breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). JPRAS Open 2022; 34: 178-188. doi: 10.1016/j.jpra.2022.08.008.

  14. Longo B, Di Napoli A, Curigliano G et al. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL. Breast. 2022; 66: 332-341. doi: 10.1016/j.breast.2022.11.009.

  15. Alessandri-Bonetti M, Jeong T, Vaienti L, De La Cruz C, Gimbel ML, Nguyen VT, Egro FM. The role of microorganisms in the development of breast implant-associated anaplastic large cell lymphoma. Pathogens 2023; 12 (2): 313. doi: 10.3390/pathogens12020313.

  16. Cuenca-Pardo J, Ramos-Gallardo G, Contreras-Bulnes L et al. Factores relacionados con las infecciones en implantes mamarios. Encuesta a miembros de la Asociación Mexicana de Cirugía Plástica. Cir Plast 2015; 25 (1): 6-14.

  17. Ramos-Gallardo G, Cuenca-Pardo J, Iribarren-Moreno R et al. Análisis de una encuesta sobre la evolución y cambio en los implantes mamarios. Cir Plast 2022; 32(4):165-171. doi: 10.35366/108770.

  18. Ramos-Gallardo G, Carballo-Zarate AA, Cuenca-Pardo J et al. What is the evidence of lymphoma in patients with prostheses other than breast implants? Aesthetic Plast Surg 2020; 44 (2): 286-294.

  19. Lista F, Tutino R, Ahmad J, Khan A. Subglandular breast augmentation with textured, anatomic, cohesive silicone implants: a review of 440 consecutive patients. Plast Reconstr Surg 2013; 132 (2): 295-303.

  20. Pompei S, Evangelidou D, Arelli F, Ferrante G. The modern polyurethane-coated implant in breast augmentation: long-term clinical experience. Aesthet Surg J 2016; 36 (10): 1124-1129.

  21. Clemens MW, DeCoster RC, Fairchild B, Bessonov AA, Santanelli di Pompeo F. Finding consensus after two decades of breast implant-associated anaplastic large cell lymphoma. Semin Plast Surg 2019; 33 (4): 270-278.

  22. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg 2017; 30 (1): 56-65.

  23. Ramos-Gallardo G, Cuenca-Pardo J, Cardenas Camarena L et al. Is Latin America ready to identify anaplastic large cell lymphoma in breast implants patients? Regional encounter during the national plastic surgery meeting in Cancun, Mexico. Aesthet Plast Surg 2018; 42 (5): 1421-1428.

  24. Quiros MC, Bolaños MC, Fassero JJ. Six-year prospective outcomes of primary breast augmentation with nano surface implants. Aesthet Surg J 2019; 39 (5): 495-508.

  25. Han J, Jeong JH, Bang SI, Heo CY. BellaGel breast implant: 4-year results of a prospective cohort study. J Plast Surg Hand Surg 2019; 53 (4): 232-239.

  26. Zingaretti N, Galvano F, Vittorini P et al. Smooth prosthesis: our experience and current state of art in the use of smooth sub-muscular silicone gel breast implants. Aesthet Plast Surg 2019; 43 (6): 1454-1466.

  27. El-Haddad R, Lafarge-Claoue B, Garabedian C, Staub S. A 10-year prospective study of implant-based breast augmentation and reconstruction. Eplasty 2018; 8 (18): e7.

  28. Barr S, Hill EW, Bayat A. Functional biocompatibility testing of silicone breast implants and a novel classification system based on surface roughness. J Mech Behav Biomed Mater 2017; 75: 75-81.

  29. Adams WP Jr, Culbertson EJ, Deva AK et al. Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg 2017; 140 (3): 427-431.

  30. Cuenca-Pardo J, Vélez-Benítez E, Ramos-Gallardo G et al. Cirugía plástica en tiempos de pandemia y de vacunas: recomendaciones de seguridad para evitar complicaciones postoperatorias (medicina basada en evidencias). Cir Plast 2022; 32: 12-27. doi: 10.35366/106104.

  31. Aminian A, Kermansaravi M, Azizi S et al. Bariatric surgical practice during the initial phase of COVID-19 outbreak. Obes Surg 2020; 30 (9): 3624-3627.

  32. Kayani B, Onochie E, Patil V et al. The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures. Bone Joint J 2020; 102-B (9): 1136-1145. doi: 10.1302/0301-620X.102B9.BJJ-2020-1127.R1.

  33. COVID Surg Collaborative. Delaying surgery for patients with a previous SARS-CoV-2 infection. B J Surg 2020; 107 (12): e601-e602.

  34. COVID Surg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anesthesia 2021; 76 (6): 748-758. doi: 10.1111/anae.15458.

  35. Royal Australasian College of Surgeon. Delaying surgery for patients recovering from COVID-19: a rapid review commissioned by RACS. RACS, April 2021. Available in: https://www.surgeons.org/-/media/Project/RACS/surgeons-org/files/news/covid19-information-hub/2021-04-23-RACS-Post-covid-delay-to-surgery-report.pdf?rev=db571f977d664e5aa7b8108a53- 1eb274&hash=15E9AC11D5D083A673E3B52DB9B3F4F

  36. Singhal R, Ludwig C, Rudge G et al. 30-day morbidity and mortality of bariatric surgery during the covid-19 pandemic: a multinational cohort study of 7704 patients from 42 countries. Obes Surg 2021; 31 (10): 4272-4288. doi: 10.1007/s11695-021-05493-9.

  37. Bui N, Coetzer M, Schenning KJ, O'Glasser AY. Preparing previously COVID-19-positive patients for elective surgery: a framework for preoperative evaluation. Perioper Med (Lond) 2021; 10 (1): 1. doi: 10.1186/s13741-020-00172-2.

  38. Sociedad Uruguaya de Neumología; Kierszenbaum M, Gutiérrez M, Musetti A, Gruss AI, Fernández L, Chao C, et al. Recomendaciones para el seguimiento respiratorio de los pacientes con complicaciones pulmonares por COVID19. SNU, mayo 2021. [Consulta: 11 junio 2021] Disponible en: https://suneumo.org/novedades/recomendaciones-para-el-seguimiento-respiratorio-de-los-pacientes-con-complicaciones-pulmonares-por-covid-19

  39. Kiyatkin ME, Levine SP, Kimura A, Linzer RW, Labins JR, Kim JI. Gurvich A, Gong MN. Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection. J Clin Anesth 2021; 74: 110409.

  40. Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, Sorkin JD, Lal BK. Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening. Am J Surg 2022; 223 (2): 380-387. doi: 10.1016/j.amjsurg.2021.04.005.

  41. Reyad KA, Abelhalim MM, Tallal RE. Prevalence of deep venous thrombosis in abdominoplasty patients after COVID-19 convalescence: an alarming flag. Plast Reconstr Surg Glob Open 2022; 10: e4196.

  42. Cuenca-Pardo J, Vélez Benítez E, Morales-Olivera M, Iribarren-Moreno R, Contreras-Bulnes L. Bucio-Duarte J. Reactivación de la consulta y cirugía electiva, durante la pandemia: recomendaciones de seguridad. Medicina Basada en evidencia. Cir Plast. 2020; 30 (1): 6-21.

  43. Reyad KA, Abelhalim MM, Tallal RE. Prevalence of deep venous thrombosis in abdominoplasty patients after COVID-19 convalescence: an alarming flag. Plast Reconstr Surg Glob Open 2022; 10: e4196.

  44. Mahrhofer M, Weitgasser L, Schoeller T. Observations of a potential immune response to breast implants after immunization with COVID-19 vaccines. Aesthet Surg J Open Forum 2021; 3 (4): ojab035.

  45. Weitgasser L, Mahrhofer M, Schoeller T. Potential immune response to breast implants after immunization with COVID-19 vaccines. Breast 2021; 59: 76-78. doi: 10.1016/j.breast.2021.06.002.

  46. Kayser F, Fourneau H, Mazy OC, Mazy S. Breast implant seroma: a SARS-CoV-2 mRNA vaccine side effect. J Clin Ultrasound 2021; 49 (9): 984-986. doi: 10.1002/jcu.23056.

  47. Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment. Arch Dermatol Res. 2022; 314 (1): 1-15. doi: 10.1007/s00403-021-02190-6.




2020     |     www.medigraphic.com